全文获取类型
收费全文 | 2698篇 |
免费 | 122篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 101篇 |
妇产科学 | 46篇 |
基础医学 | 488篇 |
口腔科学 | 82篇 |
临床医学 | 285篇 |
内科学 | 609篇 |
皮肤病学 | 119篇 |
神经病学 | 97篇 |
特种医学 | 278篇 |
外科学 | 240篇 |
综合类 | 64篇 |
预防医学 | 153篇 |
眼科学 | 36篇 |
药学 | 175篇 |
中国医学 | 1篇 |
肿瘤学 | 67篇 |
出版年
2017年 | 28篇 |
2015年 | 32篇 |
2014年 | 36篇 |
2013年 | 101篇 |
2012年 | 37篇 |
2011年 | 45篇 |
2010年 | 60篇 |
2009年 | 36篇 |
2008年 | 34篇 |
2007年 | 63篇 |
2006年 | 56篇 |
2005年 | 43篇 |
2004年 | 32篇 |
2003年 | 46篇 |
2002年 | 34篇 |
2001年 | 47篇 |
2000年 | 37篇 |
1999年 | 48篇 |
1998年 | 84篇 |
1997年 | 106篇 |
1996年 | 109篇 |
1995年 | 75篇 |
1994年 | 75篇 |
1993年 | 78篇 |
1992年 | 43篇 |
1991年 | 49篇 |
1990年 | 53篇 |
1989年 | 74篇 |
1988年 | 63篇 |
1987年 | 57篇 |
1986年 | 63篇 |
1985年 | 41篇 |
1984年 | 64篇 |
1983年 | 31篇 |
1982年 | 35篇 |
1981年 | 40篇 |
1980年 | 54篇 |
1979年 | 31篇 |
1978年 | 32篇 |
1977年 | 38篇 |
1976年 | 44篇 |
1975年 | 42篇 |
1972年 | 33篇 |
1970年 | 31篇 |
1965年 | 52篇 |
1964年 | 52篇 |
1963年 | 48篇 |
1962年 | 41篇 |
1961年 | 40篇 |
1960年 | 67篇 |
排序方式: 共有2851条查询结果,搜索用时 15 毫秒
61.
62.
The University of Oklahoma Medical Center has a comprehensive program of pediatric training, research and patient care. Establishment of the Oklahoma Health Center and its Children's Medical Center on the University campus will provide expanded opportunities for training and research in cooperation with other organizations concerned with child health and development. 相似文献
63.
Thrombocytopoietic properties of oncostatin M 总被引:1,自引:2,他引:1
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent. 相似文献
64.
65.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:6,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
66.
67.
68.
69.
70.
1. Three cases of hereditary hemolytic disease secondary to G-6-PD deficiency are described. Two of the cases were first cousins of Scotch-Irish-English descent and the mode of inheritance was believed to be sex-linked.The third case was of Turkish origin; no family studies were availale.2. The mothers, who were heterozygous for G-6-PD deficiency, showed onlyminimal expression of the defect, which was manifested by a slightly decreasedred cell survival in both mothers and an abnormal methemoglobin reductiontest in one of them.3. All three cases showed a more pronounced fall in erythrocyte ATP afterincubation with phenylhydrazine than that observed in primaquine-sensitiveNegroes whose red cells were less deficient in G-6-PD.4. It is suggested that the inability of the G-6-PD-deficient erythrocyte tomaintain adequate levels of ATP may be an important factor in the pathogenesis of the hemolytic process. Submitted on August 26, 1963 Accepted on October 24, 1963 相似文献